They say that they've been aware of minor interruptions to the supply of such vaccines throughout 2022.
However, a significant, pan-European logistical problem being experienced by Boehringer Ingelheim has raised the prospect of a further reduction in supplies in the coming months.
BEVA is liaising with the three vaccine manufacturers to quantify the impact of the shortage and to consider solutions, both to minimise the threat to equine health and to prevent disruption to equestrian competition.
Marc Laemmer, equine business head at Boehringer Ingelheim Animal Health, said: “We are currently experiencing a European-wide supply issue relating to our equine influenza and influenza-tetanus vaccines.
"This has been caused by unexpected issues following the implementation of a technology upgrade and is not a product or quality issue.
"This means that some vet practices will have difficulty obtaining sufficient influenza vaccines and there may be a shortage in the UK market.
"We understand the importance of these vaccines to equine welfare, and we are continuing to work tirelessly to find a solution so that we can return to normal supply as soon as possible.”
Amanda Melvin, equine business manager at MSD Animal Health, said: “Based on prior demand, MSD’s equine vaccines Equilis Prequenza and Equilis Prequenza Te are in full supply.
"MSD have taken steps to protect as many horses as possible at this time.
"We will continue to supply existing customers with the available MSD stock on ‘allocation’ and, where possible, to allocate stock to additional customers. Allocations are being made to our veterinary customers based on their historical demand which we believe is the most efficient way to manage the available supplies.”
Rebecca Cabrejas, equine business unit manager at Zoetis, said: “Demand for our vaccines currently exceeds what we can supply.
"Whilst we have adequate stocks to fulfil current customers’ orders unfortunately, we are not in a position to be able to supply new customers at this time.
"We will continue to work with BEVA to limit the impact of the current shortages.”
Dunfermline-based Vets Now Ltd has been announced as the winner of the Scotland regional final of the £35 Million Bank of Scotland Corporate Entrepreneur Challenge. The company, based on Pitreavie Drive, is the UK's leading provider of out of hours emergency care for animals and has secured an incredible funding package of up to £5 million, free of interest and charges for three years, to turn their expansion plans into reality.Richard Dixon, Managing Director of Vets Now Ltd, said, "I am absolutely thrilled that we have won the Scottish regional final of the Entrepreneur Challenge. A lot of time and effort went into our presentation and we knew that the competition was going to be tough. I'm very proud of our team, without who Vets Now would not be what it is today."Winning the Challenge is going to have a fundamental impact on Vets Now, taking our business to a completely new level. The funding will allow us to make substantial growth and move the business into Europe. It will also increase the range of services we can provide to customers and increase the overall profile of our organisation."Richard will now go through to the national final in December, where he will compete against the winners from six other regions across the UK for the chance to be named ‘Entrepreneur of the Year' and the opportunity to benefit from four days mentoring from one of Britain's most successful and high profile entrepreneurs.Vets Now was chosen as the winner after Richard Dixon presented his business case and plans for the future to a panel of judges, including Willie Haughey from City Refrigeration and John Anderson from The Entrepreneurial Exchange. Willie, John and the rest of the judging panel then questioned Richard in their search for an entrepreneur who displayed flair, vision and creativity, coupled with solid business acumen and impressive plans for the future. The judging was followed by a dinner and award ceremony at Stirling Castle, at which the winner was announced.For more information visit http://www.theboschallenge.co.uk/
Bimeda has announced the launch of a new teat seal which the company claims offers a significant return on investment and an opportunity for veterinary surgeons to prompt farmers to re-evaluate their dry cow therapy and mastitis control.
Bimeda's vet and head of technical services, Padraig Hyland MVB said: "Boviseal is proven to dramatically reduce mastitis in the 100 days post calving¹. Adding competition to the market will encourage farmers to re-assess their dry cow and mastitis strategies.
"The UK launch of Boviseal is a great opportunity for vets to raise the issue of the damage and cost of mastitis, and the potential savings by the correct use of a seal. Boviseal is the number one selling teat seal in the Republic of Ireland, with 2/3 of the Irish dairy cows sealed annually²."
Padraig says the evidence of the value from combined sealing and antibiotic therapy is all too clear when it comes to dry cow therapy. He cites a case study at Waterwheel Farm in Donegal, Ireland which delivered a 300% return on investment: "Combined therapy might sound costly but this two year study saw annual mastitis cases fall dramatically, from 26 per 100 cows to 9 per 100³.
"Defra figures indicate that mastitis is the most costly disease problem that UK dairy farmers face, with a typical case costing £175.00 4. When you compare that against the cost of treatment for the herd, there's no real counter argument in my opinion."
Boviseal contains 65% Bismuth Subnitrate. Padraig says the effectiveness of teat sealing is proven but correct administration is key: "It is important to note that the conventional practice of massaging into the udder after infusion is not employed - the teat seal must stay in the teat canal."
For details on best application practices, the company has developed a website, www.boviseal.co.uk with a video demonstration for correct infusion.
For further information, visit the website or contact Bimeda on 01248 725400.
References
Boehringer Ingelheim Vetmedica has launched a competition to find 12 dogs that have responded well to treatment with Vetmedin, to feature in the company's forthcoming 2012 Better Dogs calendar.
Boehringer is particularly interested in hearing about dogs with funny or quirky stories, or ones that have made a dramatic heart-warming recovery. If the submission makes it to the short list of 12 they will be featured in Vetmedin's 2012 Better Dogs Calendar which will be available to veterinary practices later in the year. In addition, the vet with the best story will win a £250 Red Letter Days' voucher with the 11 runners up winning the new BSAVA Manual of Thoracic Imaging.
In return for pet owners agreeing to their dog's story being submitted, Boehringer will send each veterinary practice a complimentary pack of either Vetmedin 1.25mg x 50 tablets or Vetmedin 5.0mg x 50 tablets, depending on the normal prescription, to give to their client.
Entries can be made either on the 2012 Better Dogs Calendar form which can be found in a recent Vetmedin mailing or via email to vetmedin.bra@boehringer-ingelheim.com. All entries should be accompanied by a photograph. Terms and conditions apply and the closing date for submissions is 30 September 2011.
For further information, please contact your Boehringer Ingelheim Vetmedica Territory Manager or call 01344 746959.
Woodley Equipment Company Ltd has announced the launch of InSight rapid diagnostic test kits. The test range includes FeLV, FIV, FeLV-FIV Combi, Giardia, Canine Heartworm, Canine Parvovirus and with more tests in development.
The test kits are available to veterinary practices across the UK and to Woodley's global veterinary diagnostic distributors. Each test is based on a sandwich lateral flow immunochromatographic assay and contains 10 cassettes per box. The company says that the diagnostic kits are simple and easy to use and will provide point of care testing direct to the veterinary practice. The kits are stored at room temperature (2⁰C - 30⁰C).
The range of InSight Rapid Diagnostic Tests includes:
To place an order, email sales@woodleyequipment.com, fax 01204 669034, or telephone 01204 669033.
For more information, visit: http://www.woodleyequipment.com/.
Veterinary scientist, Dr Alex German and veterinary nurse, Shelley Holden are joining presenter and vet, Mark Evans in a new Channel Four series exploring the secret life of dogs, the first of which airs tonight at 8:00pm.
The three-part series looks at how people's lives and those of their dogs have radically changed in the last 50 years.
Using hidden cameras, episode one investigates how dogs gain weight when their owners are not present or out at work, as well as what research is being done to understand the UK's obesity epidemic in dogs and cats.
Alex, who is head of the University's Weight Management Clinic, said: "Obesity is common in dogs and can lead to a range of illnesses and diseases.
"Although treatment for weight loss has been in existence for some time it has not been without its problems, and owners, with busy lives, can find it difficult to even understand how their dog has gained weight in the first place.
"By showing what dogs get up to out of their owner's sight, this programme explores how understanding our animals' behaviour and habits can help in producing a healthy diet and exercise regime."
Dr German has also contributed to the Channel Four website, which provides information for owners and access to case studies: http://dogs.channel4.com/fat-dogs/
To date most of these imaging procedures have been performed by vets within the group’s small animal first opinion veterinary practices.
The company says its Foundations in Diagnostic Imaging for Nurses training is designed to give its nurses more clinical stature in first opinion practice.
The programme will teach nurses the workings of an x-ray machine, common X-ray positions and contrast material.
It will also cover the principles of CT and MRI, showing how to set up and operate each piece of equipment, and how to support patients through these imaging procedures.
Finally, the course will provide the training nurses need to be able to perform ultrasounds within the current RCVS legal frameworks.
CVS says it believes this is a first in the veterinary profession
Tara Ryan, Chief Veterinary Nursing Officer at CVS said: “Imaging is a brand new area that we are starting to delegate to our nurses.
"Having heavily invested in our small animal first opinion practices over the last decade, we have a wide range of imaging equipment at many of our sites.
“Excitingly, this programme will open up the ability for nurses to start to contribute more information - to help vets identify and diagnose conditions and diseases in patients.
"It is another big step that we are taking to empower our brilliant nurses and to enable them to make a great clinical contribution towards the care of our patients – and to be the nurses they want to be.”
CVS is prioritising the consulting room and Schedule 3 delegated tasks as important areas for improving what it calls 'nurse optimisation'.
The company recognises that 'buy in' from veterinary surgeons is vital to the success of its efforts to optimise the role of its nurses, and the group has also published guidelines to provide clarity around effective delegation under Schedule 3.
The report says the greatest threat to farm animal welfare standards post-Brexit would come from UK farmers competing against cheap, imported food from countries that produce to lower standards than the UK. Therefore, the Government's wish for the UK to become a global leader in free trade is not necessarily compatible with its desire to maintain high animal welfare standards.
Noting the UK's overwhelming reliance on non-UK EU citizens to fill crucial official veterinary positions in the UK, the Committee called on the Government to ensure that the industry is able to retain or recruit qualified staff to fill these roles post-Brexit.
Responding to the report, BVA President Gudrun Ravetz said: "The report offers strong leadership and a clear message, emphasising the consumer and cross-sector consensus that current animal health and welfare standards must be at least maintained in Brexit negotiations. Prioritising these standards in trade negotiations could guarantee a unique selling point for the UK. As the report recommends, as consumers we must make sure we do not compromise quality for cost-savings in order to avoid a race to the bottom for welfare standards. We now need clarity from the Government on how underpinning processes and overarching principles, like Article 13 which ensures animal welfare requirements are fully considered in policy-setting, will be incorporated into domestic law.
"The report supports our view that animal welfare should be considered a public good and we reiterate our calls following the Secretary of State’s recent speech that a replacement CAP scheme should encompass animal welfare, animal health, disease surveillance, biodiversity and environmental stewardship to benefit not only UK producers, but consumers and wider society too.
"The EU Committee’s recognition of the vital role vets play in animal health, welfare and public health is extremely encouraging. Official Veterinarians (OVs) working in abattoirs protect and reassure UK consumers, certifying and supervising the import and export of animals and animal products to third countries. As I outlined in my evidence to the Committee, some estimates suggest 95% of OVs working in UK abattoirs graduated overseas, mostly in the EU. However, we are already hearing of fewer applicants for veterinary public health roles since the referendum.
"There are significant concerns about the potential impact of a post-Brexit veterinary workforce shortage on the UK's £100 billion agri-food sector, in terms of risking business and consumer confidence as well as the UK’s future export capability. A strong, sustainable veterinary workforce is absolutely vital to safeguarding animal health, welfare and public health post Brexit."
The competition, whi/ch is open to BVA members, has three categories:
All BVA members are encouraged to take part, whether they are a semi-professional photographer or just handy with a smart phone.
BVA President Malcolm Morley said: “This competition, showcases the unique talents, creativity and skills of BVA members.
“This year, we would love to see how our members can use their passion for photography to capture the essence of our profession. This is an opportunity to show what life as a vet is really like, to capture the hard work and challenges on camera but also to demonstrate the kindness, skills and compassion of our incredible colleagues – as well as the amazing animals they care for.
“This is your chance to show off your talents. We are so excited to see the stunning entries start to pour in and look forward to announcing the winner at this year’s BVA Live event in May.”
Images by the finalists will displayed at this year’s BVA Live event at Birmingham’s NEC on 11 – 12 May 2023.
Finalists will be contacted in advance and receive a free ticket to BVA Live so they can attend the event and the prizegiving to reveal the winners.
Winning photos will also be eligible for £250 worth of John Lewis vouchers.
www.bva.co.uk/photo-comp
Europe's largest private specialist veterinary practice, Davies Veterinary Specialists, has opened a new centre at the premises of the Hyde Park Veterinary Centre in Connaught St., London W2.
Davies Veterinary Specialists employs 40 veterinary surgeons, 23 of them RCVS Recognised Specialists and more than 50 nurses. The main hospital, based in Bedfordshire, has sophisticated diagnostic, surgical and treatment facilities and offers integrated multi-disciplinary care.
Clive Elwood, Managing Director of DVS, said: "We believe that pet owners should have easy access to the top veterinary specialists in the country. We are now bringing a team of specialists offering consultations in medicine, cardiology, ultrasonography, neurology, ophthalmology, orthopaedic and soft tissue surgery to Davies London. This will make it much easier for London vets to offer their clients a convenient referral service, with full access to state-of-the-art facilities."
The Hyde Park Veterinary Centre is a long-established central London veterinary clinic. Recently expanded and refurbished, the clinic has invested heavily in the latest diagnostic and treatment facilities for the clinical care and treatment of London's pets. Head vet Andrew Prentis said: "We are all very excited about the collaboration with Davies: this new local access to top level specialists is really going to help London's vets offer their clients the very best in veterinary care at all times."
For more information, call 0207 535 0444 or visit www.vetspecialists.co.uk/london
A new device call the Animalarm, which sends dog owners an SMS text message if the temperature in their car exceeds a preset threshold, has been launched this week.
Apparently, you can also ring the device to check what the temperature is inside your car.
The Animalarm sells for £108 inc. VAT from www.animalarm.co.uk.
Now all we need is a bit of sun.
The company points to an increasing trend across Europe towards feeding raw diets to pets, with 4% of UK cats and 10% of UK dogs now being fed raw meat and animal by-products.
The webinar, which will also look at the role of testing, offers an opportunity to learn more about the pathogens and parasites associated with raw feeding and the role of the right test at the right time.
Horiba says it's not just pets that need testing, but the raw materials used in their food.
Ian, who is Head of ESCCAP (the European Scientific Council for Companion Animal Parasites) UK & Ireland, said: “The recent trend of increasing raw feeding opens up new opportunities for pathogen transmission.
"Where raw feeding is taking place, adequate tapeworm and protozoal parasite prevention is essential to reduce zoonotic risk and economic losses.
“Testing forms an essential part of their control, and understanding this role and the diagnostic test options available will prove valuable to all veterinary professionals.”
Following Ian's presentation, there will be an open Q&A session.
Horiba’s team of veterinary specialists will also be available at the end of the webinar to discuss and advise on any testing needs, including its veterinary PCR system, the POCKIT Central.
To register, visit: https://register.gotowebinar.com/register/4306408134214190348
The International Society of Feline Medicine (ISFM) has published 'Consensus Guidelines on the Long-term use of NSAIDs in cats' in the July 2010 edition of the Journal of Feline Medicine and Surgery.
The society says it has developed the guidelines in order to try and address the major welfare issue of cats suffering unremitting and untreated chronic pain. Until recently, NSAIDs had only been licensed for short-term use in cats, but with changing licensing indications and recommendations, they are now also increasingly used for long-term treatment of cats, for example in the management of osteoarthritis.
However, in most cases where long-term use of pain relief in cats is required, there are concomitant problems with other diseases or other drugs that are being given. According to the ISFM, one of the most common concerns is whether NSAIDs can be used to treat arthritis in older cats with kidney disease. The society says that because of concerns like these, and the potential for adverse effects, cats often receive no treatment at all, and their quality of life can be severely compromised.
For this reason, the ISFM set up an international expert panel to develop practical and rational guidelines on the long-term use of NSAIDs in cats. The aim was to provide guidelines that would empower clinicians, enabling them to make sensible and rational choices, and ensure much-needed therapy is not needlessly withheld from patients.
The panel was made up of Andrew Sparkes, Duncan Lascelles, Richard Malik, Sheilah Robertson, Margie Scherk, Polly Taylor, Llibertat Real Sampietro and Reidun Heiene.
Along with the veterinary information in the guidelines, the panel also developed a brief client-facing leaflet that can be given to owners when NSAIDs are prescribed for their cats - this leaflet provides simple, clear advice on why NSAIDs are used, why they are important, but also what simple precautions avoid adverse effects, with further advice on when to seek veterinary advice to reinforce the safety message.
Both of these publications are available to download from the website www.isfm.net/toolbox
Veterinary practices are being urged to raise awareness of summer skin conditions, such as sweet itch, following research carried out by Elanco Companion Animal Health, distributor of Cavalesse, which revealed that vets only tend to be consulted after horse owners have tried to manage the condition themselves (73%), or if the clinical signs have become severe (67%), potentially leading to major welfare implications.
According to the research, this is despite the fact that over half (55%) of owners of a horse with sweet itch showed concern that their horse will suffer, and nearly half being stressed about the way the condition will affect it (47%). While many horse owners are fairly knowledgeable about the causes of sweet itch and its clinical signs, over a quarter of respondents (26%) did not start managing the condition before the midge season in the spring, which may make managing the condition more frustrating. Nearly a third (31%) stated that they had to curtail their activities with their horse due to welfare, aesthetic and behavioural issues, such as head shaking, rubbing, unpredictability and aggression.
Ed Whittle, technical consultant at Elanco Companion Animal Health said: "86% of those questioned considered sweet itch to be a very serious welfare issue if left untreated, with the worst aspects of the condition being the suffering and distress caused by the constant irritation which affects the quality of life of the horse. Over half (55%) felt that sweet itch had adversely affected the behaviour of their horse, making them difficult to handle or ride. Veterinary practices should be proactively talking to their clients about summer skin conditions such as sweet itch to help alleviate the suffering and distress caused by this frustrating disease."
Elanco says it will be joining forces with the British Horse Society (BHS), The Blue Cross, The Horse Trust, Redwings Horse Sanctuary and World Horse Welfare (WHW) to raise awareness of summer skin conditions, such as sweet itch, during Sweet Itch Awareness Month (SIAM) in March. The campaign will highlight the preventative measures that should be carried out to help alleviate sweet itch and the importance of management of the condition before the start of the midge season in the spring.
Lee Hackett, head of welfare at the BHS, said: "The results of this survey show just how important raising awareness of sweet itch is. All of us, whether we are welfare organisations or vets, need to play our part in educating owners about sweet itch in the hope that they will seek expert advice at an earlier stage and reduce the number of horses that suffer as a result of this condition."
Kerry Taylor, education officer at The Blue Cross, said: "The Blue Cross is pleased to be supporting the sweet itch campaign to raise awareness of the physical and mental impact this condition has on horses. During our May 2011 National Equine Health Survey, skin problems came out the top syndrome affecting horses, and we continue to see many horses coming into our care suffering from sweet itch. Prevention and early treatment is key to managing the potentially debilitating condition."
For further information on sweet itch, Sweet Itch Awareness Month or Cavalesse, please visit http://www.fidavet.com/, or contact Elanco Companion Animal Health, Lilly House, Priestley Road, Basingstoke, RG24 9NL, 01256 353131.
Reference
Sweet itch - effect on horse and owner. Mo Gannon & Associates. Web survey in November 2011. 351 responses - owners who have owned horses with sweet itch in the last two years.
Bayer Animal Health, maker of Advocate and organiser of the Be Lungworm Aware campaign, is warning that last year's damp summer and the mild winter conditions may lead to a continued spread of Angiostongylus vasorum in the UK.
Biodiversity & Conservation Officer for The Natural History Museum, Professor Fred Naggs, said: "An increase in the number of slug and snail populations this year would suggest there will consequently be a continued spread of the parasite. However, this depends on a number of factors: (i) the number of slugs and snails around last year, of which there were many (ii) the level of precipitation throughout the year, as slugs and snails will breed continuously when temperatures are mild to warm and there is adequate relative humidity. According to many reports in the press, last year was one of the wettest on record (iii) the survival of slugs and snails over the winter. As this winter has not been particularly harsh, reasonable numbers of slugs and snails should have survived."
In addition, a study by the RVC as shown that A. vasorum is spreading beyond the traditional geographic distribution with 20 per cent of veterinary practices across the country reporting at least one case of A. vasorum. 1
To help raise awareness of the parasite, veterinary surgeons and nurses are being encouraged to support the 'Be Lungworm Aware' campaign. The scheme will offer support and education to owners and participating vet practices throughout this month, which has been labelled 'Lungworm Awareness Month'.
Caroline Braidwood, Group Product Manager at Bayer Animal Health said: "While dog owners are becoming more aware of A. vasorum, there is still a real lack of understanding as to the warning signs associated with the condition and how to prevent or treat it. Some owners still believe that Lungworm can be prevented by using normal intestinal wormers which is not the case - Advocate is the only product that can prevent A. vasorum, and from the first application. Our aim with the 'Be Lungworm Aware' campaign is to drive pet owners to their vet practice, where they can then be informed of the danger of the parasite and educated about correct preventative treatment."
Practices can request a range of materials including a practice press pack by calling their Bayer Territory Manager. The pack is designed to promote the awareness campaign to local dog owning clients and includes a regional press release, images and other collateral including leaflets, posters and a campaign DVD for display in waiting rooms.
For more information on lungworm, visit www.lungworm.co.uk
1. Royal Veterinary College survey 2012, 1,419 veterinary practices
The British Veterinary Association has expressed concern about an increasing trend towards temporary contracts for new graduates following the release of headline figures of a survey by the Institute for Employment Studies on behalf of the RCVS.
The survey showed that the percentage of graduates leaving their first job within the first three months has significantly increased for those who graduated in 2012 and who have already left their first position. Amongst vets who graduated in 2010 and had already left their first job 7.7% had done so within the first three months; for 2011 graduates this figure is 15.9%; and for 2012 graduates it is currently 42.6%, although this percentage is likely to decrease over the next year as more of the 2012 cohort leave their first roles. The two main reasons given for leaving first jobs are poor management and temporary contracts.
Besides this unexpected increase the survey showed little change in other areas for recent graduates, although there has been a slight increase in the amount of time taken for new graduates to find their first job. The survey also revealed that over the 5 year period 16% fewer graduates found jobs in under 3 months.
BVA President Peter Jones said: "Information in this survey and that conducted by the British Equine Veterinary Association recently is valuable evidence of how the changing environment affects those entering our profession and will feed into the on-going discussion at BVA on veterinary workforce issues.
"Perhaps most worrying is the statistic that the percentage of graduates leaving their first job within the first 3 months has significantly increased. The main reasons cited are poor management and temporary contracts. The trend towards temporary contracts is very worrying in terms of job security for those just starting out in our profession.
"Poor management has long concerned the BVA and is what initially led us to establish initiatives such as the Young Vet Network, the recent graduate guide and our contracts of employment campaign. We are currently working on building that support and we are in the process of widening the network of graduate support meetings to help with moral support and networking opportunities. We also supporting the RCVS's Professional Development Phase to support new graduates in their first few years of practice and have produced a number of resources to assist with this process."
While the results show little evidence of a major impact on job prospects from the increase in graduates since the opening of Nottingham Veterinary School, BVA members remain concerned about the impact of a new school opening next year such as the one planned at the University of Surrey.
Peter Jones continued: "It is reassuring to see that overall trends are not changing significantly, however, the ease with which our graduates are getting jobs is changing. We will therefore be considering in some depth the impact that two, three or more new veterinary schools could have in the future. Rumours of yet more new veterinary schools elsewhere are a serious worry for the profession.
The company has introduced a new online range of pack inserts for several of its key products including Vetoryl, Felimazole, Metrobactin and Thyforon so veterinary practices can download and print the latest pack inserts for the treatments.
The move will ensure that practices always have access to the most up-to-date information about the prescribed medication. Dechra says it will also save time as staff will not have to copy original documents from the pack.
The pack inserts will be available via www.dechra.co.uk and www.dechra.ie. In addition, Dechra has developed dispensing envelopes which are available at no charge from wholesalers in packs of 25.
Larry King, Marketing Manager, said: "Veterinary practices often dispense pharmaceuticals from bulk which involves having to copy original pack inserts for owners.
"By printing the online pack inserts, practices will no longer have piles of inserts to store and will be safe in the knowledge they are supplying the most up to date pack insert to their clients.
"When used together, the pack inserts and dispensing envelopes provide practices with an effective solution when dispensing from bulk."
Located in Wolverhampton, the new practice uses different lighting in different parts of the building: 'cool' for public areas such as the waiting room, 'comfortable warm' for the dog, cat and exotic wards and daylight for clinical areas. The LED system uses 60% less energy than conventional lighting and requires half the number of fittings. In addition, following research in the USA at Banfield, consulting rooms are fitted with dimmable lights to ease stress for patients and clients during euthanasia.
Other highlights include a specialist cat ward that White Cross says exceeds the iCatCare Cat Friendly Clinic requirements. The ward includes raised cat kennels that are carefully positioned so that cats can’t see each other, to further minimise stress-levels. There are also separate, sound-proofed wards for dogs and exotic pets.
To reduce anxiety in dogs and cats pre- and post-surgery, the practice uses pheromone diffusers and specially composed music played in the wards.
Managing Director, Tim Harrison said: "We’re delighted to launch our latest practice in Wolverhampton, which is our most environmentally-friendly yet. We’ve incorporated the most successful attributes from all of our 15 other UK practices into its design, and it’s immediately proving popular with clients and most importantly their pets."
Clinic Director James Millington says: "The facilities and attention to detail in this practice are the best I’ve ever seen. There’s no doubt this will translate into the quality of care that our clients receive and their pets deserve."
The traditional method for detecting equine lameness is subjective, using expert visual evaluation of gait to identify the presence or absence and degree of asymmetries. The lame horse is described as having a disorder, defect or loss of function and this clinical diagnosis has associated welfare implications if the horse is still asked to perform.
The article explains how advanced computer technology is starting to change all this. Optic motion capture or the use of inertial measurement units (IMUs) is now enabling the detailed study and quantification of the horse’s gait; objective assessment against preset thresholds. The paper points out that while these digital systems can overcome the temporal and spatial limitations of the human eye they simply rely on one or a number of set gait parameters to decide about lameness and this can present obstacles.
Thresholds are forcibly based on a limited reference population, which doesn’t adequately reflect the millions of horses in the world. The individual environmental and mental conditions for each horse and its day-to-day gait variations are also not accounted for. On this basis to use the term ‘lame’ because a horse demonstrates a subtle gait alteration, causing it to fall below the threshold, could be inappropriate, particularly as it may not affect the horse’s welfare in any way.
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "An important first step is for researchers and clinicians to start to discriminate clearly between 'asymmetry' and 'lameness' and not to use these as interchangeable terms when interpreting gait analysis data. Asymmetry is often, but not always, a hallmark of lameness, but is not a clinical term, whereas lameness is."
Intervet/Schering-Plough has announced that the license for Leptavoid-H has been improved allowing concurrent use with Bovilis BVD.
Intervet/Schering Plough says that given both vaccines are typically administered in the busy pre-turnout period, this will ease on-farm workload and should help to ensure that all primary courses or boosters take place sufficiently in advance of the period of risk.
Each vaccine is to be given by separate routes and sites, to animals of 8 months or older. The concurrent use in cattle may result in fewer animal interventions, less stress and better welfare.
The studies, undertaken by Intervet/Schering Plough's R&D division in the UK, focussed on both the safety and efficacy aspects of the concurrent administration of Leptavoid-H with Bovilis BVD. The company says no systemic adverse events occurred, there was no effect on the outcome of pregnancy or milk yields and the efficacy in cattle was not compromised.
Leptavoid-H is licensed to reduce the shedding of Leptospira interrogans serovar hardjo in urine. Leptavoid-H is the only Leptospirosis vaccine licensed to improve herd fertility when Leptospira hardjo is the cause of herd infertility, and the only vaccine proven to protect stock against both strains in the UK.
The RCVS Veterinary Nurses Council has decided that the College should cease being an awarding body next year, which means it will no longer offer the vocational Level 3 Diploma in Veterinary Nursing.
The College says it will ensure that the Diploma continues to be available by transferring the intellectual property associated with the qualification, such as the question banks and systems, to another larger awarding body, in a move which is likely to take effect for the beginning of the 2012 academic year.
According to the College, this decision reflects recent changes in the regulatory Conditions of Approval for awarding bodies, which it would have been hard for the College to meet while continuing to offer the Diploma cost-effectively. The changes mainly relate to potential conflicts of interest between the College's primary role, as professional regulator that safeguards standards within the veterinary professions, and its role as an awarding body. The standards-setting role includes the regulation of education and training leading to the veterinary and VN registers, and it was felt that the College could no longer exercise this role effectively if it was also an awarding organisation, as it might be suspected of treating its internal qualifications more favourably, or of obstructing competitors.
Although the College says this has not been a problem in the past, the rules are now more stringent, and the costs of setting up a fully independent awarding body would be prohibitive.
The market for the Diploma is also likely to fragment in the future, with three other awarding bodies expressing an interest in offering a Level 3 Diploma. Any reduction in the number of students taking the RCVS Level 3 Diploma would further push up the costs, potentially making the RCVS Awarding Body unviable. A larger awarding body can take advantage of economies of scale across a range of awards in a way that the RCVS cannot.
Colonel Neil Smith, Chairman of the RCVS Awarding Body Board said: "The RCVS has been offering vocational qualifications since 1998 and the decision to cease being an awarding body has not been taken lightly.
"We have taken this decision in order to focus on our core responsibilities of professional regulation and standard setting. However, we remain committed to maintaining the Diploma, which has been carefully developed by the RCVS and the profession. This move ensures that it will stay in safe hands."
The name of the awarding body to which the qualification will be transferred has not yet been announced because the process is not complete. However, the College says it felt it was important to give those involved with the delivery of training as much notice as possible of the change. More information, and the change-over plan, will be released in due course.
Libby Earle, RCVS Head of Veterinary Nursing said: "Our priority will be effecting a smooth transfer for students, Colleges and training practices, and we are confident that the impact of the change will be minimal. Furthermore, it will be a condition of the transfer that the veterinary profession continues to have a say in the future development of the qualification."
Those students still in the process of completing the old NVQ qualifications, the accreditation of which is due to run out in 2013, will continue to be serviced by the RCVS.
As the professional regulator, the College will continue to issue RCVS certificates and badges to those who have successfully completed a registerable qualification - such as an approved vocational qualification run by another awarding body, or an RCVS-recognised veterinary nursing degree.
The Advanced Diploma in Veterinary Nursing will be unaffected by the change as the qualification is awarded by the College under its Royal Charter powers.
The survey of 102 UK veterinary students, which was carried out by Charlotte French MRCVS (pictured right) in 2020, also revealed that 74% of respondents had engaged in extracurricular CPD whilst at university, including university presentations, online conferences, webinars and in-person congresses.
98% said they were willing to be involved in extracurricular CPD if it was available.
Charlotte said: "Students are interested in CPD and their career progression, they just need a little extra help in finding the right providers and sources."
Merial Animal Health has announced that the duration of immunity for the tetanus component of Proteqflu-Te has been extended to 2 years.
Merial's Veterinary Technical Manager Kevin Whelan said: "This is a welcome new addition to the label claims for this advanced vaccine, which is the only equine flu vaccine in the UK to contain a recently updated influenza virus strain. The updated strain, innovative canarypox vector technology and now the extended tetanus duration of immunity claim make the vaccine an excellent choice for vets in the UK"
Merial says Proteqflu-Te can now be used on an alternate year basis in combination with the company's other flu vaccine, Proteqflu, which does not contain tetanus toxoid. The one year duration of immunity for the influenza component remains unchanged.
Please contact your local Merial Representative or the Merial Technical Support line on 0870 6000 123 for further information.
Vetoquinol has announced that the vouchers it provides as part of the Epiphen practice support package for monitoring and management of serum levels of phenobarbital will now be provided directly from the veterinary wholesaler and sent with each order.
One or two vouchers are provided with the 30ml and 60ml packs respectively. The vouchers come complete with a pre-paid envelope in which to send samples directly to the laboratory. Each test is valued at £19.80
For further information, contact your local Vetoquinol Territory Manager.
Vétoquinol has launched Flexadin, a new range of joint support products for cats and dogs with osteoarthritis (OA)
Robert Simpson, Flexadin Product Manager said: "This new range is made up of two products: Flexadin Plus and Flexadin Advanced, both are dietetic complementary feeds which are members of a small group of joint support products which contain Omega-3 fatty acids and Vitamin E. These ingredients are proven to aid the support of the metabolism of joints in the case of OA. Although many different joint support aids are available, not all of them contain these extra ingredients."
Vétoquinol says that in addition to Omega-3 fatty acids and Vitamin E, Flexadin Plus contains the traditional ingredients: glucosamine, chondroitin and devil's claw. Flexadin Advanced contains the novel ingredient, UCII - a type of undenatured type II collagen which has been manufactured using a patented process.
Flexadin Plus comes in two formulations, the first is specifically designed for cats/small dogs and the other is for medium/large dogs. Flexadin Advanced is specifically for dogs.
Robert added: "Flexadin Advanced has a specific property which means that the administration rate is only one chew per day whatever the weight of the dog. This has an important impact on the price per day for medium and large dogs which may require more than one tablet of traditional joint support products. This property also makes Flexadin Advanced a convenient option for owners. In addition to this benefit, UCII is becoming more and more popular due to the results of scientific studies in dogs, horses and even humans.
"We are all very excited about the advances this range can bring to veterinary practices."
Both Flexadin Plus and Advanced are presented as palatable, shaped, soft chews which come in zip-lock packs to keep the soft chews fresh and tasty. Flexadin Plus comes in packs of 90 chews whilst Flexadin Advanced comes in packs of 30 chews.
For further information about Flexadin, contact Vétoquinol on: 01280 825424.